Small molecule image-guided Surgery
Total Trials
10
As Lead Sponsor
4
As Collaborator
6
Total Enrollment
514
NCT02317705
Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer
Phase: Phase 2
Role: Lead Sponsor
Start: Dec 31, 2014
Completion: Nov 30, 2015
NCT02872701
OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules
Start: May 4, 2017
Completion: Nov 30, 2018
NCT03180307
OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer
Phase: Phase 3
Start: Jan 26, 2018
Completion: Oct 16, 2020
NCT04241315
ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting
Start: Mar 26, 2020
Completion: Nov 1, 2021
NCT06235125
Safety and Feasibility of Intraoperative Visualization With Cytalux in Children
Phase: Phase 1
Role: Collaborator
Start: Apr 8, 2024
Completion: Jan 20, 2026
NCT06434909
CYTALUX™for the Intraoperative Imaging of Prostate Cancer
Start: Sep 19, 2024
Completion: Jul 24, 2025
NCT06511037
PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis
Phase: Early Phase 1
Start: Nov 13, 2024
Completion: Nov 30, 2026
NCT06849544
Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection
Start: Apr 2, 2025
Completion: Nov 30, 2025
NCT07039526
Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.
Start: Aug 19, 2025
Completion: Dec 31, 2027
NCT07124351
Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
Phase: Phase 4
Start: Sep 5, 2025
Completion: Sep 30, 2026
Loading map...